A bill to amend title 35, United States Code, to permit separate patent extensions for each product under a patent which is subject to full regulatory review and approval.

referredUnited States· United States Congress· EN

Introduced

11 August 1988

Last action

—

Status

Referred to Subcommittee on Patents, Copyrights and Trademarks.

Summary

Amends Federal law regarding extensions of pharmaceutical patent terms to permit a separate extension for a product subject to a regulatory review period before it is put into commerce if the patent claim covers more than one: (1) product; (2) method of product use; or (3) product manufacturing method. Precludes the use of such extensions for a product other than the one for which the extension is sought.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Introduced in Senate
summary · EN · 11 August 1988
Open at official source

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/100th-congress/senate-bill/2744
Open data entity: https://api.congress.gov/v3/bill/100/s/2744